Quality assurance in corneal transplants: Donor cornea assessment and oversight

Surv Ophthalmol. 2024 May-Jun;69(3):465-482. doi: 10.1016/j.survophthal.2023.12.002. Epub 2024 Jan 8.

Abstract

The cornea is the most frequently transplanted human tissue, and corneal transplantation represents the most successful allogeneic transplant worldwide. In order to obtain good surgical outcome and visual rehabilitation and to ensure the safety of the recipient, accurate screening of donors and donor tissues is necessary throughout the process. This mitigates the risks of transmission to the recipient, including infectious diseases and environmental contaminants, and ensures high optical and functional quality of the tissues. The process can be divided into 3 stages: (1) donor evaluation and selection before tissue harvest performed by the retrieval team, (2) tissue analysis during the storage phase conducted by the eye bank technicians after the retrieval, and, (3) tissue quality checks undertaken by the surgeons in the operating room before transplantation. Although process improvements over the years have greatly enhanced safety, quality, and outcome of the corneal transplants, a lack of standardization between centers during certain phases of the process still remains, and may impact on the quality and number of transplanted corneas. Here we detail the donor screening process for the retrieval teams, eye bank operators. and ophthalmic surgeons and examine the limitations associated with each of these stages.

Keywords: Cornea donor; Corneal suitability; Corneal tissue; Corneal transplant; Eye banking; Organ donation.

Publication types

  • Review

MeSH terms

  • Cornea
  • Corneal Diseases / surgery
  • Corneal Transplantation* / methods
  • Corneal Transplantation* / standards
  • Donor Selection / methods
  • Donor Selection / standards
  • Eye Banks* / standards
  • Humans
  • Quality Assurance, Health Care*
  • Tissue Donors*
  • Tissue and Organ Procurement / standards